Retour
Fourchette du Jour
25,17 €
27,13 €
Fourchette 52 Semaines
11,51 €
29,80 €
Volume
217 413
Moyenne 50J / 200J
26,82 €
/
23,56 €
Clôture Précédente
26,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -12,4 | 0,4 |
| P/B | 6,2 | 2,9 |
| ROE % | -41,2 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
45,60 €
+77.4%
Low: 38,00 €
High: 60,00 €
BPA Prévisionnel
-3,10 €
CA Est.
1,3 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,29 €
1,29 € – 1,29 €
|
570 M | 4 |
| FY2028 |
-1,06 €
-3,24 € – 0,58 €
|
260 M | 6 |
| FY2027 |
-2,54 €
-3,55 € – -1,77 €
|
61 M | 8 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -120,67M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-41,18%
ROIC-40,68%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio12,60
Interest Coverage0,00
Valorisation
P/E Ratio
-12,44
P/B Ratio6,23
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -134,22M |
| ROE | -41,18% | ROA | -46,06% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -120,67M |
| ROIC | -40,68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 12,60 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -12,44 | P/B Ratio | 6,23 |
| P/S Ratio | N/A | PEG Ratio | 1,31 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,67B | Enterprise Value | 1,39B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -134,22M | -100,88M | -76,33M | -42,73M | -29,62M |
| EPS (Diluted) | -2,48 | -2,63 | -2,27 | -1,41 | -0,85 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | -8 436,95 |
| Operating Income | -145,69M | -96,91M | -86,71M | -54,14M | -28,51M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 291,37M | 398,69M | 167,73M | 212,09M | 101,10M |
| Total Liabilities | 23,61M | 14,65M | 18,47M | 7,14M | 5,31M |
| Shareholders' Equity | 267,76M | 384,05M | 149,26M | 204,95M | 95,79M |
| Total Debt | 861 470,0 | 238 905,0 | 436 822,0 | 250 184,0 | 0,0 |
| Cash & Equivalents | 280,73M | 391,23M | 161,84M | 209,35M | 98,63M |
| Current Assets | 289,42M | 397,85M | 166,85M | 211,57M | 100,95M |
| Current Liabilities | 22,97M | 14,60M | 18,22M | 6,99M | 5,31M |